|
CA1247080A
(en)
|
1983-03-08 |
1988-12-20 |
Commonwealth Serum Laboratories Commission |
Antigenically active amino acid sequences
|
|
IL86278A
(en)
|
1988-05-04 |
2003-06-24 |
Yeda Res & Dev |
Endowing cells with antibody specificity using chimeric t cell receptor
|
|
US5906936A
(en)
|
1988-05-04 |
1999-05-25 |
Yeda Research And Development Co. Ltd. |
Endowing lymphocytes with antibody specificity
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
US5199942A
(en)
|
1991-06-07 |
1993-04-06 |
Immunex Corporation |
Method for improving autologous transplantation
|
|
IL104570A0
(en)
|
1992-03-18 |
1993-05-13 |
Yeda Res & Dev |
Chimeric genes and cells transformed therewith
|
|
US8211422B2
(en)
|
1992-03-18 |
2012-07-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Chimeric receptor genes and cells transformed therewith
|
|
JP3614866B2
(ja)
|
1997-06-12 |
2005-01-26 |
リサーチ コーポレイション テクノロジーズ，インコーポレイティド |
人工抗体ポリペプチド
|
|
TWI224995B
(en)
|
1998-03-19 |
2004-12-11 |
Ciba Sc Holding Ag |
Stabilization of wood substrates
|
|
US7754208B2
(en)
|
2001-01-17 |
2010-07-13 |
Trubion Pharmaceuticals, Inc. |
Binding domain-immunoglobulin fusion proteins
|
|
CZ20033208A3
(en)
|
2001-04-26 |
2004-03-17 |
Biogen, Inc. |
Cripto blocking antibodies and uses thereof
|
|
PT1421115E
(pt)
|
2001-08-31 |
2005-07-29 |
Avidex Ltd |
Receptor de celulas t soluvel
|
|
IL159422A0
(en)
|
2001-09-20 |
2004-06-01 |
Cornell Res Foundation Inc |
Methods and compositions for treating or preventing skin disorders using binding agents specific for prostate-specific membrane antigen
|
|
US20050123536A1
(en)
|
2001-11-20 |
2005-06-09 |
Che-Leung Law |
Treatment of immunological disorders using anti-dc30 antibodies
|
|
US6992176B2
(en)
|
2002-02-13 |
2006-01-31 |
Technion Research & Development Foundation Ltd. |
Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
|
|
AU2003216341A1
(en)
|
2002-02-20 |
2003-09-09 |
Dyax Corporation |
Mhc-peptide complex binding ligands
|
|
AU2003271904B2
(en)
|
2002-10-09 |
2009-03-05 |
Adaptimmune Limited |
Single chain recombinant T cell receptors
|
|
GB0304068D0
(en)
*
|
2003-02-22 |
2003-03-26 |
Avidex Ltd |
Substances
|
|
CU23403A1
(es)
|
2003-04-23 |
2009-08-04 |
Centro Inmunologia Molecular |
Anticuerpos recombinantes y fragmentos que reconocen el gangliósido n-glicolil gm3 y su uso para diagnóstico y tratamiento de tumores
|
|
US7709610B2
(en)
|
2003-05-08 |
2010-05-04 |
Facet Biotech Corporation |
Therapeutic use of anti-CS1 antibodies
|
|
AR044388A1
(es)
|
2003-05-20 |
2005-09-07 |
Applied Molecular Evolution |
Moleculas de union a cd20
|
|
NZ550815A
(en)
|
2004-05-19 |
2009-04-30 |
Immunocore Ltd |
Method of improving T cell receptors
|
|
WO2005113595A2
(en)
|
2004-05-19 |
2005-12-01 |
Avidex Ltd |
High affinity ny-eso t cell receptor
|
|
AU2005250408B2
(en)
*
|
2004-05-27 |
2010-09-23 |
The Trustees Of The University Of Pennsylvania |
Novel artificial antigen presenting cells and uses therefor
|
|
ES2382627T3
(es)
|
2004-06-29 |
2012-06-12 |
B.R.A.H.M.S Gmbh |
Nuevos anticuerpos monoclonales estimuladores o bloqueadores de la tiroides, secuencias peptídicas que corresponden a sus regiones variables, y sus usos en medicina diagnóstica, preventiva y terapéutica
|
|
EP1846454A2
(en)
|
2004-09-30 |
2007-10-24 |
Medarex, Inc. |
Human monoclonal antibodies to fc gamma receptor ii (cd32)
|
|
EP1809669A2
(en)
*
|
2004-10-01 |
2007-07-25 |
Avidex Ltd |
T-cell receptors containing a non-native disulfide interchain bond linked to therapeutic agents
|
|
DE602005022928D1
(de)
|
2004-11-30 |
2010-09-23 |
Abgenix Inc |
Antikörper gegen gpnmb und ihre verwendungen
|
|
CA2593212A1
(en)
|
2005-01-05 |
2006-07-13 |
Biogen Idec Ma Inc. |
Cripto binding molecules
|
|
DOP2006000029A
(es)
|
2005-02-07 |
2006-08-15 |
Genentech Inc |
Antibody variants and uses thereof. (variantes de un anticuerpo y usos de las mismas)
|
|
WO2007002223A2
(en)
|
2005-06-20 |
2007-01-04 |
Medarex, Inc. |
Cd19 antibodies and their uses
|
|
NZ569236A
(en)
|
2005-12-08 |
2012-06-29 |
Medarex Inc |
Human monoclonal antibodies to protein tyrosine kinase 7 (PTK7) and their use
|
|
EA017491B1
(ru)
|
2005-12-08 |
2012-12-28 |
Медарекс, Инк. |
Человеческие моноклональные антитела к фукозил-gm1 и способы применения антифукозил-gm1 антител
|
|
AU2006332155B2
(en)
|
2005-12-30 |
2013-01-10 |
Cancer Research Technology Limited |
Anti-CD19 antibodies with reduced immunogenicity
|
|
US20080131428A1
(en)
|
2006-02-24 |
2008-06-05 |
Arius Research, Inc. |
Cytotoxicity mediation of cells evidencing surface expression of TROP-2
|
|
EP2650306A1
(en)
|
2006-03-06 |
2013-10-16 |
Aeres Biomedical Limited |
Humanized Anti-CD22 antibodies and their use in treatment of oncology, transplantation and autoimmune disease
|
|
PT2032606E
(pt)
|
2006-05-30 |
2014-02-05 |
Genentech Inc |
Anticorpos e imunoconjugados e respetivas utilizações
|
|
US8323653B2
(en)
|
2006-09-08 |
2012-12-04 |
Medimmune, Llc |
Humanized anti-CD19 antibodies and their use in treatment of oncology, transplantation and autoimmune disease
|
|
CN103497148B
(zh)
|
2007-02-22 |
2016-06-01 |
科尔比制药公司 |
羟胺化合物及其用法
|
|
EP2014302A1
(en)
|
2007-07-12 |
2009-01-14 |
Institut Curie |
An antibody specific for the Tn antigen for the treatment of cancer
|
|
EP2186825A1
(en)
*
|
2008-11-13 |
2010-05-19 |
Max-Delbrück-Centrum für Molekulare Medizin (MDC) |
Human-derived T cell receptors
|
|
UA109633C2
(uk)
|
2008-12-09 |
2015-09-25 |
|
Антитіло людини проти тканинного фактора
|
|
MX2011008611A
(es)
|
2009-02-16 |
2011-10-21 |
Biolex Therapeutics Inc |
Anticuerpos anti-cd20 humanizados y metodos de uso.
|
|
CA2753158A1
(en)
|
2009-02-23 |
2010-08-26 |
Glenmark Pharmaceuticals S.A. |
Humanized antibodies that bind to cd19 and their uses
|
|
WO2010107658A2
(en)
|
2009-03-16 |
2010-09-23 |
Vallera Daniel A |
Methods and compositions for bi-specific targeting of cd19/cd22
|
|
NZ616382A
(en)
|
2009-04-20 |
2015-04-24 |
Oxford Biotherapeutics Ltd |
Antibodies specific to cadherin-17
|
|
WO2011009090A1
(en)
|
2009-07-16 |
2011-01-20 |
Xoma Technology Ltd. |
Antibodies to high molecular weight melanoma associated antigen
|
|
MY173390A
(en)
|
2009-10-23 |
2020-01-22 |
Takeda Pharmaceuticals Co |
Anti-gcc antibody molecules and related compositions and methods
|
|
WO2011059836A2
(en)
|
2009-10-29 |
2011-05-19 |
Trustees Of Dartmouth College |
T cell receptor-deficient t cell compositions
|
|
US20120269814A1
(en)
|
2009-11-10 |
2012-10-25 |
Amgen Inc. |
Anti-c mpl antibodies
|
|
CA2793753C
(en)
|
2010-03-26 |
2018-06-05 |
Memorial Sloan-Kettering Cancer Center |
Antibodies to muc16 and methods of use thereof
|
|
ES2601182T3
(es)
|
2010-05-11 |
2017-02-14 |
Fred Hutchinson Cancer Research Center |
Variantes de clorotoxina, conjugados y métodos para su utilización
|
|
US9932403B2
(en)
|
2010-05-20 |
2018-04-03 |
Ablynx Nv |
Biological materials related to HER3
|
|
EP2409993A1
(en)
|
2010-07-19 |
2012-01-25 |
International-Drug-Development-Biotech |
Anti-CD19 antibody having ADCC function with improved glycosylation profile
|
|
WO2012012695A2
(en)
|
2010-07-23 |
2012-01-26 |
Fred Hutchinson Cancer Research Center |
A method for the treatment of obesity
|
|
AR082641A1
(es)
|
2010-09-07 |
2012-12-19 |
Imclone Llc |
Composiciones de anticuerpo anti-vegfr-3
|
|
WO2012042026A1
(en)
|
2010-09-30 |
2012-04-05 |
Ablynx Nv |
Biological materials related to c-met
|
|
UA112062C2
(uk)
|
2010-10-04 |
2016-07-25 |
Бьорінгер Інгельхайм Інтернаціональ Гмбх |
Cd33-зв'язувальний агент
|
|
CA2816379A1
(en)
|
2010-10-27 |
2012-05-03 |
Baylor College Of Medicine |
Chimeric cd27 receptors for redirecting t cells to cd70-positive malignancies
|
|
ES2785081T3
(es)
|
2011-04-01 |
2020-10-05 |
Memorial Sloan Kettering Cancer Center |
Anticuerpos biespecíficos similares a receptores de células T específicos para un péptido de WT1 presentado por HLA-A2
|
|
EP2714737A1
(en)
|
2011-05-27 |
2014-04-09 |
Glaxo Group Limited |
Bcma (cd269/tnfrsf17) -binding proteins
|
|
AU2012267710A1
(en)
|
2011-06-08 |
2014-01-23 |
The Regents Of The University Of California |
Anti-CD22 antigen binding molecules to treat lung cancer and prostate cancer
|
|
WO2013019730A1
(en)
|
2011-07-29 |
2013-02-07 |
The Washington University |
Antibodies to tip-1 and grp78
|
|
SG10201606785UA
(en)
|
2011-08-16 |
2016-10-28 |
Morphosys Ag |
Combination therapy with an anti - cd19 antibody and a nitrogen mustard
|
|
WO2013059343A1
(en)
|
2011-10-17 |
2013-04-25 |
Massachusetts Institute Of Technology |
Intracellular delivery
|
|
TWI679212B
(zh)
|
2011-11-15 |
2019-12-11 |
美商安進股份有限公司 |
針對ｂｃｍａ之e3以及ｃｄ３的結合分子
|
|
US20130302274A1
(en)
|
2011-11-25 |
2013-11-14 |
Roche Glycart Ag |
Combination therapy
|
|
CN104520324A
(zh)
|
2012-02-24 |
2015-04-15 |
施特姆森特Rx股份有限公司 |
Dll3调节剂及其使用方法
|
|
WO2013130565A1
(en)
|
2012-02-29 |
2013-09-06 |
The Brigham And Women's Hosptial, Inc. |
Neutralizing antibody for epstein barr virus associated disease
|
|
KR20140148411A
(ko)
|
2012-03-12 |
2014-12-31 |
메디뮨 엘엘씨 |
항-cd19 항체를 이용한 다발성 경화증의 치료
|
|
US9163090B2
(en)
|
2012-05-07 |
2015-10-20 |
Cellerant Therapeutics, Inc. |
Antibodies specific for CLL-1
|
|
WO2013167153A1
(en)
|
2012-05-09 |
2013-11-14 |
Ganymed Pharmaceuticals Ag |
Antibodies useful in cancer diagnosis
|
|
US20130309223A1
(en)
|
2012-05-18 |
2013-11-21 |
Seattle Genetics, Inc. |
CD33 Antibodies And Use Of Same To Treat Cancer
|
|
SG10201806573TA
(en)
|
2012-05-25 |
2018-09-27 |
Cellectis |
Methods for engineering allogeneic and immunosuppressive resistant t cell for immunotherapy
|
|
WO2014039513A2
(en)
|
2012-09-04 |
2014-03-13 |
The Trustees Of The University Of Pennsylvania |
Inhibition of diacylglycerol kinase to augment adoptive t cell transfer
|
|
US9416190B2
(en)
|
2012-09-27 |
2016-08-16 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Mesothelin antibodies and methods for eliciting potent antitumor activity
|
|
US9695228B2
(en)
|
2012-11-21 |
2017-07-04 |
Janssen Biotech, Inc. |
EGFR and c-Met fibronectin type III domain binding molecules
|
|
EP2738180A1
(en)
|
2012-11-30 |
2014-06-04 |
Molecular Partners AG |
Binding proteins comprising at least two binding domains against HER2.
|
|
US9803021B2
(en)
|
2012-12-07 |
2017-10-31 |
The Regents Of The University Of California |
CD138-targeted interferon demonstrates potent apoptotic and anti-tumor activities
|
|
SG11201504920SA
(en)
|
2012-12-27 |
2015-07-30 |
Sanofi Sa |
Anti-lamp1 antibodies and antibody drug conjugates, and uses thereof
|
|
EP2948478B1
(en)
|
2013-01-25 |
2019-04-03 |
Amgen Inc. |
Antibodies targeting cdh19 for melanoma
|
|
IL298125A
(en)
|
2013-02-26 |
2023-01-01 |
Memorial Sloan Kettering Cancer Center |
Preparations and methods for immunotherapy
|
|
HK1220111A1
(zh)
|
2013-03-05 |
2017-04-28 |
Baylor College Of Medicine |
人类t淋巴细胞中类肝素酶的表达
|
|
CN105339498A
(zh)
|
2013-03-07 |
2016-02-17 |
贝勒医学院 |
癌症中靶向cd138
|
|
EP2970312B1
(en)
|
2013-03-11 |
2017-11-15 |
The Regents of The University of Michigan |
Bet bromodomain inhibitors and therapeutic methods using the same
|
|
EP2970492B1
(en)
|
2013-03-15 |
2019-05-08 |
Wake Forest University Health Sciences |
Antibodies against human and canine il-13ra2
|
|
UY35468A
(es)
|
2013-03-16 |
2014-10-31 |
Novartis Ag |
Tratamiento de cáncer utilizando un receptor quimérico de antígeno anti-cd19
|
|
US9790282B2
(en)
|
2013-03-25 |
2017-10-17 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anti-CD276 polypeptides, proteins, and chimeric antigen receptors
|
|
CN104140974B
(zh)
|
2013-05-08 |
2017-09-29 |
科济生物医药（上海）有限公司 |
编码gpc‑3嵌合抗原受体蛋白的核酸及表达gpc‑3嵌合抗原受体蛋白的t淋巴细胞
|
|
EP2997134B1
(en)
|
2013-05-14 |
2020-06-24 |
Board of Regents, The University of Texas System |
Human application of engineered chimeric antigen receptor (car) t-cells
|
|
CA2913052A1
(en)
|
2013-05-24 |
2014-11-27 |
Board Of Regents, The University Of Texas System |
Chimeric antigen receptor-targeting monoclonal antibodies
|
|
CA2913872C
(en)
|
2013-05-31 |
2022-01-18 |
Cellectis |
A laglidadg homing endonuclease cleaving the t-cell receptor alpha gene and uses thereof
|
|
GB201313377D0
(en)
|
2013-07-26 |
2013-09-11 |
Adaptimmune Ltd |
T cell receptors
|
|
EP3027755B1
(en)
|
2013-08-02 |
2019-10-09 |
The Regents of The University of California |
Engineering antiviral t cell immunity through stem cells and chimeric antigen receptors
|
|
EP2839842A1
(en)
|
2013-08-23 |
2015-02-25 |
MacroGenics, Inc. |
Bi-specific monovalent diabodies that are capable of binding CD123 and CD3 and uses thereof
|
|
EP2840091A1
(en)
|
2013-08-23 |
2015-02-25 |
MacroGenics, Inc. |
Bi-specific diabodies that are capable of binding gpA33 and CD3 and uses thereof
|
|
GB201317929D0
(en)
|
2013-10-10 |
2013-11-27 |
Ucl Business Plc |
Chimeric antigen receptor
|
|
AU2014337385B2
(en)
|
2013-10-15 |
2020-04-30 |
The Scripps Research Institute |
Chimeric antigen receptor T cell switches and uses thereof
|
|
US10144770B2
(en)
|
2013-10-17 |
2018-12-04 |
National University Of Singapore |
Chimeric receptors and uses thereof in immune therapy
|
|
US10246505B2
(en)
|
2013-11-25 |
2019-04-02 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Chimeric antigen receptors to control HIV infection
|
|
WO2015080981A1
(en)
|
2013-11-27 |
2015-06-04 |
Baylor College Of Medicine |
Csgp4-specific chimeric antigen receptor for cancer
|
|
AR098743A1
(es)
|
2013-12-13 |
2016-06-08 |
Genentech Inc |
Anticuerpos e inmunoconjugados anti-cd33
|
|
US10214584B2
(en)
|
2014-01-15 |
2019-02-26 |
Order-Made Medical Research Inc. |
Therapeutic pharmaceutical composition employing anti-SLC6A6 antibody
|
|
EP3097117B1
(en)
|
2014-01-21 |
2023-10-04 |
Novartis Ag |
Enhanced antigen presenting ability of car t cells by co-introduction of costimulatory molecules
|
|
WO2015120180A1
(en)
|
2014-02-05 |
2015-08-13 |
The University Of Chicago |
Chimeric antigen receptors recognizing cancer-specific tn glycopeptide variants
|
|
RU2744046C2
(ru)
|
2014-03-05 |
2021-03-02 |
Отолус Лимитед |
ХИМЕРНЫЙ АНТИГЕННЫЙ РЕЦЕПТОР (CAR) С АНТИГЕНСВЯЗЫВАЮЩИМИ ДОМЕНАМИ К КОНСТАНТНОЙ ОБЛАСТИ β Т-КЛЕТОЧНОГО РЕЦЕПТОРА
|
|
GB201403875D0
(en)
|
2014-03-05 |
2014-04-16 |
Cantargia Ab |
Novel antibodies and uses thereof
|
|
CN122399016A
(zh)
|
2014-03-15 |
2026-07-17 |
诺华股份有限公司 |
使用嵌合抗原受体治疗癌症
|
|
CN106459165B
(zh)
|
2014-04-01 |
2021-04-20 |
拜恩科技细胞&基因治疗有限公司 |
密封蛋白-6特异性免疫受体和t细胞表位
|
|
GB201406767D0
(en)
|
2014-04-15 |
2014-05-28 |
Cancer Rec Tech Ltd |
Humanized anti-Tn-MUC1 antibodies anf their conjugates
|
|
WO2015164759A2
(en)
|
2014-04-25 |
2015-10-29 |
Bluebird Bio, Inc. |
Mnd promoter chimeric antigen receptors
|
|
EP3166968B1
(en)
|
2014-05-02 |
2021-09-22 |
The Trustees of the University of Pennsylvania |
Compositions and methods of chimeric autoantibody receptor t cells
|
|
EP2944652A1
(en)
*
|
2014-05-13 |
2015-11-18 |
Technische Universität München |
Glypican-3-specific T-cell receptors and their uses for immunotherapy of hepatocellular carcinoma
|
|
PT3149031T
(pt)
*
|
2014-05-29 |
2020-03-25 |
Us Health |
Receptores de células t anti-e7 do papilomavírus humano 16
|
|
US9212225B1
(en)
|
2014-07-01 |
2015-12-15 |
Amphivena Therapeutics, Inc. |
Bispecific CD33 and CD3 binding proteins
|
|
JP6831777B2
(ja)
|
2014-07-21 |
2021-02-17 |
ノバルティス アーゲー |
Ｃｄ３３キメラ抗原受容体を使用する癌の処置
|
|
AU2015292744C1
(en)
|
2014-07-21 |
2021-01-21 |
Novartis Ag |
Treatment of cancer using humanized anti-BCMA chimeric antigen receptor
|
|
AR101669A1
(es)
|
2014-07-31 |
2017-01-04 |
Amgen Res Munich Gmbh |
Constructos de anticuerpos para cdh19 y cd3
|
|
EP3177314B1
(en)
*
|
2014-08-04 |
2020-10-07 |
Fred Hutchinson Cancer Research Center |
T cell immunotherapy specific for wt-1
|
|
MX2017001946A
(es)
|
2014-08-12 |
2017-06-19 |
Novartis Ag |
Conjugados de farmacos con anticuerpos anti-cdh6.
|
|
EP3180359A1
(en)
|
2014-08-14 |
2017-06-21 |
Novartis AG |
Treatment of cancer using gfr alpha-4 chimeric antigen receptor
|
|
JP6588084B2
(ja)
|
2014-08-19 |
2019-10-09 |
ミルテニイ バイオテック ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Ｓｓｅａ４抗原に特異的なキメラ抗原受容体
|
|
ES2688035T3
(es)
|
2014-08-29 |
2018-10-30 |
Gemoab Monoclonals Gmbh |
Receptor de antígeno universal que expresa células inmunes para direccionamiento de antígenos múltiples diversos, procedimiento para fabricación del mismo y utilización del mismo para tratamiento de cáncer, infecciones y enfermedades autoinmunes
|
|
US10093746B2
(en)
|
2014-09-04 |
2018-10-09 |
The Trustees Of The University Of Pennsylvania |
Glypican-3 antibody and uses thereof
|
|
DK3189081T3
(da)
|
2014-09-05 |
2020-05-04 |
Janssen Pharmaceutica Nv |
Cd123-bindende midler og anvendelser deraf
|
|
WO2016040441A1
(en)
|
2014-09-09 |
2016-03-17 |
Unum Therapeutics |
Chimeric receptors and uses thereof in immune therapy
|
|
MA40579A
(fr)
|
2014-09-12 |
2016-03-17 |
Genentech Inc |
Anticorps anti-cll-1 et immunoconjugués
|
|
US20160081314A1
(en)
|
2014-09-19 |
2016-03-24 |
Regeneron Pharmaceuticals, Inc. |
Chimeric Antigen Receptors
|
|
ES2851123T1
(es)
|
2014-09-26 |
2021-09-03 |
Baylor College Medicine |
Receptores quiméricos de antígeno específicos de glipicano-3 para inmunoterapia adoptiva
|
|
US20170335290A1
(en)
|
2014-10-31 |
2017-11-23 |
Baylor College Of Medicine |
Survivin specific t-cell receptor targeting tumor but not t cells
|
|
CA2966005C
(en)
|
2014-10-31 |
2021-04-27 |
Abbvie Biotherapeutics Inc. |
Anti-cs1 antibodies and antibody drug conjugates
|
|
ES2809455T3
(es)
|
2014-11-17 |
2021-03-04 |
Regeneron Pharma |
Métodos para tratamiento tumoral usando anticuerpo biespecífico CD3xCD20
|
|
AU2015357535B2
(en)
|
2014-12-05 |
2020-05-14 |
Eureka Therapeutics, Inc. |
Antibodies targeting G-protein coupled receptor and methods of use
|
|
HRP20210582T1
(hr)
|
2014-12-05 |
2021-09-03 |
Memorial Sloan Kettering Cancer Center |
Antitijela koja ciljaju antigen sazrijevanja b-stanice i postupci uporabe
|
|
DK3227339T3
(da)
|
2014-12-05 |
2022-01-10 |
Memorial Sloan Kettering Cancer Center |
Kimæriske antigenreceptorer rettet mod g-protein-koblet receptor og anvendelser deraf
|
|
US10383929B2
(en)
|
2014-12-12 |
2019-08-20 |
Bluebird Bio, Inc. |
BCMA chimeric antigen receptors
|
|
HRP20240357T1
(hr)
|
2014-12-24 |
2024-06-07 |
Autolus Limited |
Stanica
|
|
AR103488A1
(es)
|
2015-01-23 |
2017-05-10 |
Sanofi Sa |
Anticuerpos anti-cd3, anticuerpos anti-cd123 y anticuerpos biespecíficos que se unen específicamente a cd3 y/o cd123
|
|
EP3250602A1
(en)
|
2015-01-26 |
2017-12-06 |
Cellectis |
T cell receptor knock out engineered immune cells, endowed with chimeric antigen receptors binding to cd123 for the treatment of relapsed/refractory acute myeloid lymphoma or blastic plasmacytoid dendritic cell neoplasm
|
|
WO2016126488A1
(en)
|
2015-02-02 |
2016-08-11 |
Sea Lane Biotechnologies, Llc |
Anti-surrogate light chain antibodies
|
|
WO2016154047A2
(en)
|
2015-03-20 |
2016-09-29 |
Memorial Sloan-Kettering Cancer Center |
Monoclonal antigen-binding proteins to intracellular oncogene products
|
|
BR112017020750A2
(en)
|
2015-03-27 |
2018-06-26 |
President And Fellows Of Harvard College |
modified t-cells and methods of producing and using them
|
|
EP3273994B1
(en)
|
2015-03-27 |
2021-12-01 |
University of Southern California |
Car t-cell therapy directed to lhr for the treatment of solid tumors
|
|
TWI700298B
(zh)
|
2015-04-13 |
2020-08-01 |
美商輝瑞股份有限公司 |
靶向ｂ細胞成熟抗原之嵌合型抗原受體類
|
|
WO2016168595A1
(en)
|
2015-04-17 |
2016-10-20 |
Barrett David Maxwell |
Methods for improving the efficacy and expansion of chimeric antigen receptor-expressing cells
|
|
WO2016176639A1
(en)
|
2015-04-30 |
2016-11-03 |
University Of Southern California |
Secretory tnt car cell immunotherapy
|
|
JP7366518B2
(ja)
|
2015-05-06 |
2023-10-23 |
ヤンセン バイオテツク，インコーポレーテツド |
前立腺特異的膜抗原結合フィブロネクチンｉｉｉ型ドメイン
|
|
HRP20191800T1
(hr)
|
2015-05-13 |
2019-12-27 |
Ablynx N.V. |
Polipeptidi koji regrutiraju t stanice koji se temelje na tcr alfa/beta reaktivnosti
|
|
EP3770168A1
(en)
*
|
2015-05-18 |
2021-01-27 |
TCR2 Therapeutics Inc. |
Compositions and methods for tcr reprogramming using fusion proteins
|
|
IL281396B
(en)
|
2015-06-09 |
2022-07-01 |
Memorial Sloan Kettering Cancer Center |
T cell receptor-like antibody agents specific for ebv latent membrane protein 2a peptide presented by human hla
|
|
US9422547B1
(en)
|
2015-06-09 |
2016-08-23 |
Gigagen, Inc. |
Recombinant fusion proteins and libraries from immune cell repertoires
|
|
WO2017040195A1
(en)
|
2015-08-28 |
2017-03-09 |
The Trustees Of The University Of Pennsylvania |
Methods and compositions for cells expressing a chimeric intracellular signaling molecule
|
|
CA2999070A1
(en)
|
2015-09-17 |
2017-03-23 |
Novartis Ag |
Car t cell therapies with enhanced efficacy
|
|
JP7085990B2
(ja)
|
2015-10-13 |
2022-06-17 |
シティ・オブ・ホープ |
クロロトキシンドメインを含むキメラ抗原レセプター
|
|
MX2018004721A
(es)
*
|
2015-10-23 |
2018-07-06 |
Eureka Therapeutics Inc |
Construcciones quimericas anticuerpo/receptor de celulas t y usos de las mismas.
|
|
BR112018008908A2
(pt)
|
2015-11-02 |
2018-11-27 |
Janssen Pharmaceutica Nv |
anticorpos anti-il1rap, moléculas de ligação ao antígeno biespecíficas que se ligam il1rap e cd3, e seus usos
|
|
AU2017240233B2
(en)
|
2016-03-31 |
2022-07-14 |
University Of Southern California |
A highly sensitive and specific luciferase based reporter assay for antigen detection
|
|
NZ746700A
(en)
|
2016-04-01 |
2023-04-28 |
Kite Pharma Inc |
Bcma binding molecules and methods of use thereof
|
|
KR102427334B1
(ko)
|
2016-04-01 |
2022-08-03 |
카이트 파마 인코포레이티드 |
키메라 항원 및 t 세포 수용체 및 사용 방법
|
|
WO2017190100A1
(en)
|
2016-04-28 |
2017-11-02 |
The Trustees Of Dartmouth College |
Nucleic acid constructs for co-expression of chimeric antigen receptor and transcription factor, cells containing and therapeutic use thereof
|
|
WO2017192536A1
(en)
*
|
2016-05-02 |
2017-11-09 |
University Of Kansas |
Eliminating mhc restriction from the t cell receptor as a strategy for immunotherapy
|
|
EP3484496B1
(en)
|
2016-07-14 |
2023-12-27 |
University of Southern California |
Methods and composition for producing and using immune cells and stem cells for cell-based therapies
|
|
BR112019000683A2
(pt)
|
2016-07-15 |
2019-04-24 |
Poseida Therapeutics Inc |
receptores de antígeno quiméricos e métodos para uso
|
|
EP3516068B1
(en)
|
2016-09-19 |
2025-04-23 |
University of Southern California |
Non-radioactive cytotoxicity assays
|
|
JP7700039B2
(ja)
|
2019-01-04 |
2025-06-30 |
マレンゴ・セラピューティクス，インコーポレーテッド |
抗ｔｃｒ抗体分子およびその使用
|